Filter by Topic
- (-) Remove Experiments filter Experiments
- Publications (17) Apply Publications filter
- Reproduction (12) Apply Reproduction filter
- People (5) Apply People filter
- Disorders (4) Apply Disorders filter
- Processes (4) Apply Processes filter
- Technologies (4) Apply Technologies filter
- Organisms (3) Apply Organisms filter
- Ethics (2) Apply Ethics filter
- Theories (1) Apply Theories filter
Filter by Format
- (-) Remove Articles filter Articles
Corticosteroids' Effect on Fetal Lung Maturation (1972), by Sir Graham Collingwood Liggins and Ross Howie
In a clinical trial from 1969 to 1972, Sir Graham Collingwood Liggins and Ross Howie showed that if doctors treat pregnant women with corticosteroids before those women deliver prematurely, then those women's infants have fewer cases of respiratory distress syndrome than do similarly premature infants of women not treated with corticosteroids. Prior to the study, premature infants born before 32 weeks of gestation often died of respiratory distress syndrome, or the inability to inflate immature lungs.
"Transfer of Fetal Cells with Multilineage Potential to Maternal Tissue" (2004), by Kiarash Khosrotehrani et al.
In 2004, a team of researchers at Tufts-New England
Medical Center in Boston, Massachusetts, investigated the fetal
cells that remained in the maternal blood stream after pregnancy.
The results were published in Transfer of Fetal Cells with
Multilineage Potential to Maternal Tissue. The team working on that
research included Kiarash Khosrotehrani, Kirby L. Johnson, Dong
Hyun Cha, Robert N. Salomon, and Diana W. Bianchi. The researchers
reported that the fetal cells passed to a pregnant woman during
Subject: Experiments, Reproduction
The British Doctors’ Study (1951–2001)
From 1951 to 2001, researchers at the University of Oxford in Oxford, England, conducted the British Doctors’ Study, a study that examined the smoking habits, disease rates, and mortality rates of physicians in Britain. Two epidemiologists, scientists who study occurrence and distribution of disease, Richard Doll and Austin Bradford Hill, initiated the study, and statistician Richard Peto joined the team in 1971. The objective of the study was to assess the risks associated with tobacco use, and its relationship to lung cancer.
HIP Randomized Breast Cancer Screening Trial (1963–1982)
From 1963 to 1982, researchers in New York City, New York, carried out a randomized trial of mammography screening. Mammography is the use of X-ray technology to find breast cancer at early stages. The private insurance company Health Insurance Plan of Greater New York, or HIP, collaborated with researchers Sam Shapiro, Philip Strax, and Louis Venet on the trial. The researchers’ goal was to determine whether mammography screening reduced breast cancer mortality in women. The study included sixty thousand women aged forty to sixty-four.
"A Stochastic Model of Stem Cell Proliferation, Based on the Growth of Spleen Colony-Forming Cells” (1964) by James Till, Ernest McCulloch, and Louis Siminovitch
In 1964, authors James Till, Ernest McCulloch, and Louis Siminovitch, published A Stochastic Model of Stem Cell Proliferation, Based on The Growth of Spleen Colony-Forming Cells, which discussed possible mechanisms that control stem cell division. The authors wrote the article following their experiments with spleens of irradiated mice to demonstrate the existence of stem cells, had unknown properties.
Roger Sperry’s Split Brain Experiments (1959–1968)
In the 1950s and 1960s, Roger Sperry performed experiments on cats, monkeys, and humans to study functional differences between the two hemispheres of the brain in the United States. To do so he studied the corpus callosum, which is a large bundle of neurons that connects the two hemispheres of the brain. Sperry severed the corpus callosum in cats and monkeys to study the function of each side of the brain. He found that if hemispheres were not connected, they functioned independently of one another, which he called a split-brain.
Management of Myelomeningocele Study Clinical Trial (2003–2010)
From February 2003 to December 2010, researchers of the Management of Myelomeningocele Study, or MOMS, clinical trial compared the safety and efficacy of different treatments for a specific type of spina bifida, called myelomeningocele. Myelomeningocele, the most frequent and severe form of spina bifida, is a condition in which the bony spinal column does not develop correctly, which causes an opening of the spine, exposure of the spinal cord, and formation of a small sac containing cerebrospinal fluid.